Qatar Tourism (QT) and Mwani Qatar announced the return of the 2022/2023 cruise season, expecting the arrival of more than 50 cruise liners with approximately 200,000 visitors from now to the end of April 2023. A press release by Qatar Tourism tod..
The total number of inbound visitors to the State of Qatar recorded an annual increase of 430.3% in November 2022, compared to same period in 2021 (November 2021), and a monthly increase of 229.5%, compared to October 2022. According to the new issu..
Elon Musk has urged a federal judge to shift a trial in a shareholder lawsuit out of San Francisco because he says negative local media coverage has biased potential jurors against him. Instead, in a filing submitted late Friday — less than ..
At least 40 people were killed and dozens injured in a bus crash in central Senegal, the country’s president said Sunday. President Macky Sall tweeted that the collision happened in Gnivy village, in the Kaffrine region, at about 3:30 a.m. ..
Doha Festival City (DFC) announced the temporary closure of the mall's east side and the access from the bridge and Lusail, via their official Twitter handle on 7 January 2023. The mall is temporarily accessible only from the west side, ..
The Qatar Youth Council, affiliated with the Ministry of Sports and Youth, held its first meeting, where a speaker and a deputy-speaker were elected in a direct secret ballot. The poll results showed electing Nawaf Mohammed Al Mudhaka as council s..
A passenger airplane made an emergency landing in central Japan following a bomb threat on Saturday. An airplane flown by budget carrier Jetstar Japan made an emergency landing at Chubu Airport following a bomb threat, though no device was found, ..
A new state-of-the-art Translational and Precision Medicine Research Laboratory (T&PML) has been launched at the Women's Wellness and Research Center (WWRC) to focus on high priority maternal and neonatal health disorders, such as preterm bir..
The US Food and Drug Administration granted accelerated approval for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. The FDA said the drug is for pati..